'It started with a tingle in my thigh - now I'll never walk again'
When Ashleigh Talbot first noticed a slight tingling at the top of her left thigh, she didn’t think much of it. Working at ...
Celeb Tattler on MSN13h
Selma Blair’s Honest Take on Life with MS
Renowned for her acting in Legally Blonde and Cruel Intentions Selma Blair openly speaks of having multiple sclerosis (MS) ...
The i on MSN18h
I’m an Olympic medallist with MS – this is why I went public with my diagnosis
Team GB athlete Lina Nielsen is starting treatment for multiple sclerosis – a decade after being diagnosed. She tells The i Paper she now wants to help others too ...
Multiple Sclerosis News Today1d
Floodlight MS app cost-effective for patients to track their health: Study
The Floodlight MS app, used to track disease progression in people with multiple sclerosis, has been deemed cost-effective in ...
Sunshine in pregnancy, infancy could help children with multiple sclerosis
Children who develop multiple sclerosis appear to fare better if they were exposed to safe amounts of summer sunshine as ...
Knowridge2d
Scientists find a major cause of multiple sclerosis
Multiple sclerosis (MS) is a disease that affects the brain and spinal cord. It happens when the body’s immune system ...
STAT2d
The FDA must remove an unnecessary barrier to the use of clozapine for treatment-resistant schizophrenia
If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...
Multiple Sclerosis News Today2d
Australia, New Zealand get consensus guidelines for MS care
Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...
Dual-target drug may lead to new treatment approach for breast cancer patients
Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...
Neurology Advisor2d
FDA: Anaphylaxis Risk Prompts Boxed Warning for MS Drug
Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.
Biogen's stock slides on soft guidance and a decline in sales of MS drugs
The company is expecting 2025 EPS to range from $15.25 to $16.25, below the $16.33 FactSet consensus. Revenue is expected to decline by a mid-single-digit percent on a constant currency basis, as ...